Showing results (101-110 of 196) with videos related to

Sort By:
Pageof 20
Canadian Association of Radiologists Journal = Journal L'Association Canadienne Des Radiologistes|April 10, 2020
Emergent Comprehensive Imaging of the Major Trauma Patient: A New Paradigm for Improved Clinical Decision-MakingSadia Raheez Qamar, David Evans, Brian Gibney, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|March 25, 2004
Assessment of arginine 97 and lysine 72 as determinants of substrate specificity in cytochrome P450 2C9 (CYP2C9)Carwyn Davies, Katey Witham, Justin R Scott, et al.
Cancer Research|February 27, 2009
Acquired resistance to 17-allylamino-17-demethoxygeldanamycin (17-AAG, tanespimycin) in glioblastoma cellsNathalie Gaspar, Swee Y Sharp, Simon Pacey, et al.
Molecular and Cellular Neurosciences|April 21, 2023
Deletion of PTEN in microglia ameliorates chronic neuroinflammation following repetitive mTBIAndrew Pearson, Camila Ortiz, Max Eisenbaum, et al.
Chembiochem : a European Journal of Chemical Biology|June 2, 2019
Biochemical Characterization of Full-Length Oncogenic BRAFV600E together with Molecular Dynamics Simulations Provide Insight into the Activation and Inhibition Mechanisms of RAF KinasesNicholas Cope, Borna Novak, Christine Candelora, et al.
AJR. American Journal of Roentgenology|October 24, 2007
Perioperative endovascular internal iliac artery occlusion balloon placement in management of placenta accretaCher Heng Tan, Kiang Hiong Tay, Kenneth Sheah, et al.
Cardiology Journal|June 22, 2013
Intravenous versus intracoronary bolus of glycoprotein IIb/IIIa inhibitor administration during primary percutaneous coronary intervention on long-term left ventricular systolic and diastolic functionPierpaolo Pellicori, Concetta Torromeo, Francesco Barillà, et al.
BMC Neurology|August 29, 2020
Molecular abnormalities in autopsied brain tissue from the inferior horn of the lateral ventricles of nonagenarians and Alzheimer disease patientsAndrew Pearson, Rosa Ajoy, Gogce Crynen, et al.
Cancer Biotherapy & Radiopharmaceuticals|July 14, 2007
Dosimetry for fractionated (131)I-mIBG therapies in patients with primary resistant high-risk neuroblastoma: preliminary resultsSusan E Buckley, Frank H Saran, Mark N Gaze, et al.
Molecular Cancer Therapeutics|May 12, 2010
Mechanistic evaluation of the novel HSP90 inhibitor NVP-AUY922 in adult and pediatric glioblastomaNathalie Gaspar, Swee Y Sharp, Suzanne A Eccles, et al.
Pageof 20